To: Rhonda Robb Re: Separation Agreement and Release Dear Rhonda:Cardiovascular Systems Inc • August 18th, 2022 • Surgical & medical instruments & apparatus • Minnesota
As you know, your employment with Cardiovascular Systems, Inc. (“CSI”) will end effective at the close of business on June 6, 2022 (the “Separation Date). The purpose of this Separation Agreement and Release letter (“Agreement”) is to set forth the Salary Continuation Benefits and other benefits CSI will provide to you in exchange for your agreement to the terms and conditions of this Agreement. Capitalized terms used but not otherwise defined in this Agreement will have the meaning set forth in CSI’s Executive Officer Severance Plan dated August 22, 2018 (the “Executive Officer Severance Plan”). Please note that while we are giving this Agreement to you now for review, you may not execute this Agreement before your Separation Date.
RESTRICTED STOCK AGREEMENT PERFORMANCE-BASED VESTING (REVENUE GROWTH) CARDIOVASCULAR SYSTEMS, INC.Restricted Stock Agreement • August 18th, 2022 • Cardiovascular Systems Inc • Surgical & medical instruments & apparatus • Minnesota
CARDIOVASCULAR SYSTEMS, INC., a Delaware corporation (the “Company”) has engaged Morgan Stanley Smith Barney LLC (“MSSB”) to maintain an online system to provide secure account access to participants receiving grants (each, a “Participant”) under the Company’s Amended and Restated 2017 Equity Incentive Plan (as the same may be amended from time to time, the “Plan”). Each Participant has an online account with MSSB with an award summary (the “Award Summary”) disclosing the date of the award, the number of shares subject to each award and conditions of the vesting of the award. This Agreement sets forth terms and conditions applicable to those awards set forth in the Award Summary that are subject to performance-based vesting.
David Whitescarver [ADDRESS REDACTED] Re: Separation Agreement and Release Dear David:Cardiovascular Systems Inc • August 18th, 2022 • Surgical & medical instruments & apparatus • Minnesota
As you know, your retirement will be effective and your employment with Cardiovascular Systems, Inc. (“CSI”) will end effective at the close of business on June 30, 2022 (the “Separation Date”), due to your voluntary resignation. The purpose of this Separation Agreement and Release (“Agreement”) is to set forth the separation benefits CSI agreed to offer to you per the transition letter agreement between the parties dated December 16, 2021 to facilitate a smooth transition and in exchange for your agreement to the terms and conditions of this Agreement. Please note that while we are giving this Agreement to you now for review, you may not execute this Agreement before your Separation Date.
CONSULTING AGREEMENTConsulting Agreement • August 18th, 2022 • Cardiovascular Systems Inc • Surgical & medical instruments & apparatus • Minnesota
CSI and Consultant desire to enter into an arrangement by which Consultant will provide consulting services to CSI pursuant to the terms and conditions contained in this Agreement.
